Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Beaumont, K' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 34 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Webster, R; Beaumont, K; Ritzau, M; Stachulski, AV
      The synthesis of the glucuronide metabolite of UK-157,147 using immobilised uridine 5 '-diphosphoglucuronyl transferase and traditional organic chemistry techniques (imidate method)

      BIOCATALYSIS AND BIOTRANSFORMATION
    2. Ethell, BT; Beaumont, K; Rance, DJ; Burchell, B
      Use of cloned and expressed human UDP-glucuronosyltransferases for the assessment of human drug conjugation and identification of potential drug interactions

      DRUG METABOLISM AND DISPOSITION
    3. van de Waterbeemd, H; Smith, DA; Beaumont, K; Walker, DK
      Property-based design: Optimization of drug absorption and pharmacokinetics

      JOURNAL OF MEDICINAL CHEMISTRY
    4. Beaumont, K; Harper, A; Smith, DA; Bennett, J
      The role of P-glycoprotein in determining the oral absorption and clearance of the NK2 antagonist, UK-224,671

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    5. Beaumont, K; Harper, A; Smith, DA; Abel, S
      Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rat, dogand human

      XENOBIOTICA
    6. Beaumont, K; Negulescu, P
      Chipping away at GPCR function

      NATURE BIOTECHNOLOGY
    7. AMACHER DE; FASULO LM; CHARUEL C; COMBY P; BEAUMONT K
      IN-VITRO TOXICITY OF ZAMIFENACIN (UK-76,654) AND METABOLITES IN PRIMARY HEPATOCYTE CULTURES

      Xenobiotica
    8. BEAUMONT K; GEDULIN B; JODKA C; LAWLER R; YOUNG A
      CONCENTRATION-RESPONSE FOR GLUCAGONOSTATIC EFFECT OF PRAMLINTIDE IN RATS

      Diabetologia
    9. ETHELL BT; ANDERSON GD; BEAUMONT K; RANCE DJ; BURCHELL B
      A UNIVERSAL RADIOCHEMICAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF UDP-GLUCURONOSYLTRANSFERASE ACTIVITY

      Analytical biochemistry
    10. CHEN WJ; ARMOUR S; WAY J; CHEN G; WATSON C; IRVING P; COBB J; KADWELL S; BEAUMONT K; RIMELE T; KENAKIN T
      EXPRESSION CLONING AND RECEPTOR PHARMACOLOGY OF HUMAN CALCITONIN RECEPTORS FROM MCF-7 CELLS AND THEIR RELATIONSHIP TO AMYLIN RECEPTORS

      Molecular pharmacology
    11. LARKIN S; MULL E; MIAO W; PITTNER R; ALBRANDT K; MOORE C; YOUNG A; DENARO M; BEAUMONT K
      REGULATION OF THE 3RD MEMBER OF THE UNCOUPLING PROTEIN FAMILY, UCP3, BY COLD AND THYROID-HORMONE

      Biochemical and biophysical research communications
    12. YOUNG AA; VINE W; GEDULIN BR; PITTNER R; JANES S; GAETA LSL; PERCY A; MOORE CX; KODA JE; RINK TJ; BEAUMONT K
      PRECLINICAL PHARMACOLOGY OF PRAMLINTIDE IN THE RAT - COMPARISONS WITHHUMAN AND RAT AMYLIN

      Drug development research
    13. VINE W; BEAUMONT K; GEDULIN B; PITTNER R; MOORE CX; RINK TJ; YOUNG AA
      COMPARISON OF THE IN-VITRO AND IN-VIVO PHARMACOLOGY OF ADRENOMEDULLIN, CALCITONIN-GENE-RELATED PEPTIDE AND AMYLIN IN RATS

      European journal of pharmacology
    14. JANES S; GAETA L; BEAUMONT K; BEELEY N; RINK T
      THE SELECTION OF PREILLUMINATED FOR CLINICAL-EVALUATION

      Diabetes
    15. PITTNER R; WOLFELOPEZ D; BEAUMONT K; RINK T
      LACK OF EFFECT OF AMYLIN ON MAJOR MARKERS OF GLYCOGENOLYSIS AND GLUCONEOGENESIS ON ISOLATED RAT HEPATOCYTES

      Diabetes
    16. PITTNER RA; WOLFELOPEZ D; YOUNG AA; BEAUMONT K
      DIFFERENT PHARMACOLOGICAL CHARACTERISTICS IN L(6) AND C2C12 MUSCLE-CELLS AND INTACT RAT SKELETAL-MUSCLE FOR AMYLIN, CGRP AND CALCITONIN

      British Journal of Pharmacology
    17. DILTS RP; KENNEY M; BEAUMONT K
      AUTORADIOGRAPHIC LOCALIZATION OF BINDING-SITES FOR AMYLIN AND AMYLIN ANTAGONISTS IN RAT-KIDNEY

      Journal of the American Society of Nephrology
    18. WATSON CA; CHEN G; IRVING P; COBB JE; BEAUMONT K; PRICKETT KS; RIMELE T; KENAKIN TP
      THE PHARMACOLOGY OF AMYLIN RECEPTORS IN THE RAT NUCLEUS-ACCUMBENS - EFFECTS OF RECEPTOR G-PROTEIN INTERACTIONS ON LIGAND AFFINITY

      The FASEB journal
    19. PITTNER R; BEAUMONT K; YOUNG A; RINK T
      DOSE-DEPENDENT ELEVATION OF CYCLIC-AMP, ACTIVATION OF GLYCOGEN-PHOSPHORYLASE, AND RELEASE OF LACTATE BY AMYLIN IN RAT SKELETAL-MUSCLE

      Biochimica et biophysica acta. Molecular cell research
    20. YOUNG AA; WANG MW; GEDULIN B; RINK TJ; PITTNER R; BEAUMONT K
      DIABETOGENIC EFFECTS OF SALMON-CALCITONIN ARE ATTRIBUTABLE TO AMYLIN-LIKE ACTIVITY

      Metabolism, clinical and experimental
    21. ALBRANDT K; BRADY EMG; MOORE CX; MULL E; SIERZEGA ME; BEAUMONT K
      MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF A 3RD ISOFORM OF THE HUMAN CALCITONIN RECEPTOR AND PARTIAL CHARACTERIZATION OF THE CALCITONIN RECEPTOR GENE

      Endocrinology
    22. BEAUMONT K; MOORE CX; PITTNER RA; PRICKETT KS; GAETA LSL; RINK TJ; YOUNG AA
      DIFFERENTIAL ANTAGONISM OF AMYLINS METABOLIC AND VASCULAR ACTIONS WITH AMYLIN RECEPTOR ANTAGONISTS

      Canadian journal of physiology and pharmacology
    23. CHRISTOPOULOS G; PAXINOS G; HUANG XF; BEAUMONT K; TOGA AW; SEXTON PM
      COMPARATIVE DISTRIBUTION OF RECEPTORS FOR AMYLIN AND THE RELATED PEPTIDES CALCITONIN-GENE-RELATED PEPTIDE AND CALCITONIN IN RAT AND MONKEY BRAIN

      Canadian journal of physiology and pharmacology
    24. BEAUMONT K; PITTNER RA; MOORE CX; WOLFELOPEZ D; PRICKETT KS; YOUNG AA; RINK TJ
      REGULATION OF MUSCLE GLYCOGEN-METABOLISM BY CGRP AND AMYLIN - CGRP RECEPTORS NOT INVOLVED

      British Journal of Pharmacology
    25. PITTNER RA; ALBRANDT K; BEAUMONT K; GAETA LSL; KODA JE; MOORE CX; RITTENHOUSE J; RINK TJ
      MOLECULAR PHYSIOLOGY OF AMYLIN

      Journal of cellular biochemistry
    26. SEXTON PM; PAXINOS G; KENNEY MA; WOOKEY PJ; BEAUMONT K
      IN-VITRO AUTORADIOGRAPHIC LOCALIZATION OF AMYLIN BINDING-SITES IN RAT-BRAIN

      Neuroscience
    27. YOUNG AA; GEDULIN B; GAETA LSL; PRICKETT KS; BEAUMONT K; LARSON E; RINK TJ
      SELECTIVE AMYLIN ANTAGONIST SUPPRESSES RISE IN PLASMA LACTATE AFTER INTRAVENOUS GLUCOSE IN THE RAT - EVIDENCE FOR A METABOLIC ROLE OF ENDOGENOUS AMYLIN

      FEBS letters
    28. BEAUMONT K; MOORE CX; PITTNER R; PRICKETT K; GAETA LSL; RINK TJ; YOUNG AA
      DIFFERENTIAL PHARMACOLOGICAL ANTAGONISM OF AMYLIN AND CGRP RECEPTORS

      Diabetologia
    29. PITTNER RA; WOLFELOPEZ D; LUPIEN J; BEAUMONT K; YOUNG AA; RINK TJ
      AMYLIN INCREASES CYCLIC-AMP LEVELS AND STIMULATES GLYCOGENOLYSIS IN RAT SKELETAL-MUSCLE

      Diabetologia
    30. BEAUMONT K; KENNEY MA; YOUNG AA; RINK TJ
      HIGH-AFFINITY AMYLIN BINDING-SITES IN RAT-BRAIN

      Molecular pharmacology
    31. ALBRANDT K; MULL E; BRADY EMG; HERICH J; MOORE CX; BEAUMONT K
      MOLECULAR-CLONING OF 2 RECEPTORS FROM RAT-BRAIN WITH HIGH-AFFINITY FOR SALMON-CALCITONIN

      FEBS letters
    32. BEAUMONT K; KENNEY MA; WOLFELOPEZ D; ALBRECHT EA; GAETA LSL
      A RECEPTOR ANTAGONIST SELECTIVE FOR AMYLIN OVER CGRP BLOCKS AMYLINS METABOLIC ACTIONS

      Diabetes
    33. KENNEY MA; MOORE CX; PITTNER R; BEAUMONT K
      SALMON-CALCITONIN BINDING AND STIMULATION OF CYCLIC-AMP GENERATION INRAT SKELETAL-MUSCLE

      Biochemical and biophysical research communications
    34. RINK TJ; BEAUMONT K; KODA J; YOUNG A
      STRUCTURE AND BIOLOGY OF AMYLIN

      Trends in pharmacological sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 12:48:07